HaaPACS GmbH
Industry / private company
Location:
Schriesheim,
Germany (DE)
Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis (2026)
Hart A, Navabi S, D'Haens G, Matsuoka K, Martín-Arranz MD, Atreya R, Samaan KH, et al.
Journal article
Baricitinib as monotherapy for treatment of rheumatoid arthritis: analysis of real-world data (2024)
Edwards CJ, Takeuchi T, Finckh A, Kleyer A, Haladyj E, Gerwien JG, Treuer T, et al.
Journal article, Review article
Clinical characteristics, treatment patterns, and persistence in individuals with type 2 diabetes initiating a glucagon-like peptide-1 receptor agonist: A retrospective analysis of the Diabetes Prospective Follow-Up Registry (2023)
Jung H, Tittel SR, Schloot NC, Heitmann E, Otto T, Lebrec J, Pavel ME, Lanzinger S
Journal article